|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
TL-310
|
MedKoo Code#: 202960
|
|
Name: TL-310
|
|
CAS#: 352697-38-2
Synonym:
IUPAC/Chemical name:
2-Furanpropanoic acid, .alpha.-hydroxy-.beta.-[[(2-methylpropoxy)carbonyl]amino]-,
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-6-[(cyclopropylcarbonyl)oxy]-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl
ester, (.alpha.R,.beta.R)-
|
|
Chemical structure |
Theoretical analysis
|
|
|
Chemical Formula: C45H55NO16
Exact Mass: 865.35208
Molecular Weight: 865.91
m/z: 865.35208 (100.0%), 866.35544 (48.7%),
867.35879 (11.6%), 867.35633 (3.3%), 868.36215 (1.8%), 868.35969
(1.6%)
Elemental Analysis: C, 62.42; H, 6.40; N,
1.62; O, 29.56
|
|
Availability and price:
This agent is not in stock, which may be available through custom synthesis. To inquire quotation and lead time or to ask questions, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Information about this agent
|
TL310 is a novel, oral taxane with potent
pre-clinical activity in taxane-resistant model systems. This is the
first study to evaluate the safety, tolerability and pharmacokinetics
(PK) of TL310 in pts with advanced refractory solid tumors
Current developer:
Taxolog Inc.
Singh, Chandra Ulagaraj. Solid nanoparticle
formulation of water insoluble pharmaceuticals with reduced Ostwald
ripening. PCT Int. Appl. (2008), 134pp. CODEN: PIXXD2 WO 2008013785 A2
20080131 CAN 148:198644 AN 2008:124314
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
